Bharat Immunologicals and Biologicals Corporation: Difference between revisions

Created by BrownHairedGirl
Last edited August 22, 2021
>BrownHairedGirl
+ 4 categories using HotCat
 
>DaxServer
m Add back cat per discussion WP:TCAT using Pywikibot category add
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
{{Short description|Indian public sector company}}
{{EngvarB|date=February 2014}}
{{EngvarB|date=February 2014}}
{{Use dmy dates|date=February 2014}}
{{Use dmy dates|date=February 2014}}
{{Infobox company
{{Infobox company
| name            = Bharat Immunologicals and Biologicals Corporation Limited
| name            = Bharat Immunologicals and Biologicals Corporation
| native_name      = <!-- Company's name in home country language -->
| native_name      = <!-- Company's name in home country language -->
| native_name_lang = <!-- Use ISO 639-2 code, e.g. "fr" for French. If there is more than one native name, in different languages, enter those names using {{tl|lang}}, instead. -->
| native_name_lang = <!-- Use ISO 639-2 code, e.g. "fr" for French. If there is more than one native name, in different languages, enter those names using {{tl|lang}}, instead. -->
| trading_name    = <!-- d/b/a/, doing business as - if different from legal name above -->
| trading_name    = <!-- d/b/a/, doing business as - if different from legal name above -->
| logo            =  
| logo            = BIBCOL logo.jpg
| logo_caption    =  
| logo_caption    =  
| image            =  
| image            =  
Line 47: Line 47:
| bodystyle        =  
| bodystyle        =  
}}
}}
'''Bharat Immunologicals and Biologicals Corporation Limited''' ('''BIBCOL''') is a [[Public Sector Undertaking]] (PSU) of the [[Government of India]].  Established in 1989 in [[Bulandshahar]], [[Uttar Pradesh]], BIBCOL manufactures [[polio vaccine|oral polio vaccine]]s (OPVs) and other immunisers.  The company formulates over 125 million doses of OPV and had aggregated revenues of {{INRConvert|305|m}} in fiscal 2006.<ref name=bibcol>[http://www.dbtindia.nic.in/institutions/PSUs/bibcol.html Company Profile]. Department of Biotechnology.</ref><ref name=bib2>[http://dpe.nic.in/survey0506/vol3/267.pdf Financial Statement]. Department of Public Enterprise</ref>
'''Bharat Immunologicals and Biologicals Corporation Limited''' ('''BIBCOL''') is a [[Public Sector Undertaking]] (PSU) of the [[Government of India]].  Established in 1989 in [[Bulandshahar]], [[Uttar Pradesh]], BIBCOL manufactures [[polio vaccine|oral polio vaccine]]s (OPVs) and other immunisers.<ref>{{Cite web|date=2021-05-12|title=BIBCOL to manufacture 20 million doses of ‘covaxin’ every month {{!}} Web News Observer|url=https://webnewsobserver.com/2021/05/12/bibcol-to-manufacture-20-million-doses-of-covaxin-every-month/|access-date=2021-05-12|language=en-US}}</ref> The company formulates over 12.5 [[crore]] doses of OPV and had aggregated revenues of {{INRConvert|30.5|c|year=2006}} in fiscal 2006.<ref name=bibcol>[http://www.dbtindia.nic.in/institutions/PSUs/bibcol.html Company Profile]. Department of Biotechnology.</ref><ref name=bib2>[http://dpe.nic.in/survey0506/vol3/267.pdf Financial Statement]. Department of Public Enterprise</ref>


BIBCOL is under the administrative control of the [[Department of Biotechnology]], [[Ministry of Science and Technology (India)|Ministry of Science and Technology]].
BIBCOL is under the administrative control of the [[Department of Biotechnology]], [[Ministry of Science and Technology (India)|Ministry of Science and Technology]].
Line 55: Line 55:
#[[Diarrhea]] Management Kit—Diarrhea Management Kit ([[Zinc]] Tablet + [[oral rehydration salts]] (ORS)) for management of diarrhea among young children.
#[[Diarrhea]] Management Kit—Diarrhea Management Kit ([[Zinc]] Tablet + [[oral rehydration salts]] (ORS)) for management of diarrhea among young children.
#Oral [[Polio Vaccine]]—The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1, 2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary by monkey kidney cell culture.
#Oral [[Polio Vaccine]]—The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1, 2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary by monkey kidney cell culture.
#Zinc Dispersible Tablet—The dispersible zinc tablet, BIBZinC-20&nbsp;mg contains 20&nbsp;mg of elemental zinc as active ingredient and contains sweetener and taste masker (Vanilla flavor) and is scored tablet. The product is in line with the recommendations of the WHO. The product is produced with technology transfer from [[Nutriset]] (French company) through the Department of Biotechnology, Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation and safety.
#Zinc Dispersible Tablet—The dispersible zinc tablet, BIBZinC-20&nbsp;mg contains 20&nbsp;mg of elemental zinc as active ingredient and contains sweetener and taste masker (Vanilla flavor) and is scored tablet. The product is in line with the recommendations of the WHO. The product is produced with technology transfer from [[Nutriset]] through the [[Department of Biotechnology]], Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation and safety.
#IFA Tablets—[[Iron-deficiency anemia]] (IDA) is most ignored in developing countries and is the major cause of [[anemia]]. The Iron Folic Tablets (IFA Tablets) are a crucial component for treatment of [[iron deficiency]] and IDA.
#IFA Tablets—[[Iron-deficiency anemia]] (IDA) is most ignored in developing countries and is the major cause of [[anemia]]. The Iron Folic Tablets (IFA Tablets) are a crucial component for treatment of [[iron deficiency]] and IDA.


Line 66: Line 66:
== External links ==
== External links ==
* http://www.bibcol.com/ (Official Website)
* http://www.bibcol.com/ (Official Website)


{{authority control}}
{{authority control}}
Line 78: Line 77:
[[Category:Bulandshahr]]
[[Category:Bulandshahr]]
[[Category:Health care companies established in 2009]]
[[Category:Health care companies established in 2009]]
 
[[Category:Companies listed on the Bombay Stock Exchange]]


{{india-company-stub}}
{{india-company-stub}}

Latest revision as of 20:49, 22 August 2021


Bharat Immunologicals and Biologicals Corporation
Traded asBSE524663
Key people
Sh. Chandra Prakash Goyal
(Managing Director)
ProductsPolio vaccine
OwnerGovernment of India
Websitebibcol.com

Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Public Sector Undertaking (PSU) of the Government of India. Established in 1989 in Bulandshahar, Uttar Pradesh, BIBCOL manufactures oral polio vaccines (OPVs) and other immunisers.[1] The company formulates over 12.5 crore doses of OPV and had aggregated revenues of 30.5 crore (equivalent to 79 crore or US$11 million in 2019) in fiscal 2006.[2][3]

BIBCOL is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology.

Products[edit | edit source]

  1. Diarrhea Management Kit—Diarrhea Management Kit (Zinc Tablet + oral rehydration salts (ORS)) for management of diarrhea among young children.
  2. Oral Polio Vaccine—The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1, 2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary by monkey kidney cell culture.
  3. Zinc Dispersible Tablet—The dispersible zinc tablet, BIBZinC-20 mg contains 20 mg of elemental zinc as active ingredient and contains sweetener and taste masker (Vanilla flavor) and is scored tablet. The product is in line with the recommendations of the WHO. The product is produced with technology transfer from Nutriset through the Department of Biotechnology, Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation and safety.
  4. IFA Tablets—Iron-deficiency anemia (IDA) is most ignored in developing countries and is the major cause of anemia. The Iron Folic Tablets (IFA Tablets) are a crucial component for treatment of iron deficiency and IDA.

See also[edit | edit source]

References[edit | edit source]

  1. "BIBCOL to manufacture 20 million doses of 'covaxin' every month | Web News Observer". 12 May 2021. Retrieved 12 May 2021.
  2. Company Profile. Department of Biotechnology.
  3. Financial Statement. Department of Public Enterprise

External links[edit | edit source]